Covid-19 & IP: the race is on for big the pharmaceuticals industry
Vaccines for the recent virus seem to be rolling out one after the other since the start of 2021, and... View Article
Vaccines for the recent virus seem to be rolling out one after the other since the start of 2021, and... View Article
Whether we have spent our 2020 working from home, learning something new or just relaxing, many of us had more... View Article
With Joe Biden being the president elect in the US election, there are questions rising about the effects that his... View Article
Welcome to the Let’s talk IP series where we will tap in the IP world and explore the top 3... View Article
What’s mine, is yours ? In the extremely digitised age we are living in, there are many technologies which change... View Article
The impact of IP on M&A transactions In a previous blog post we announced the merger between Clarivate Plc and... View Article
Over the last 16 years The Cambridgeshire Prestige Guide is sent out to over 500,000 subscribers on a national basis,... View Article
We’ve seen a lot of changes in the business landscape since COVID-19 hit the country. While most of the country has been under strict shelter-in-place orders, things at present seem to be relaxing...
Chairman Dr. Chris Donegan, Managing Director of Invention Capital Associations kicked of the 4 sections throughout day 1. We hosted... View Article
Intellectual property is the creation of the mind: it can be music you wrote, the software you built, the clothes... View Article
Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, have announced... View Article
“Virtually connecting the worlds of Business and IP” - the first ever live and interactive IP summit - 8th to 9th July 2020, hosted by conference Chair, Chris Donegan of Invention Capital Associates.
From the IP department to the boardroom: How IP intelligence and data analysis will enable commercially focused decision making. Organised... View Article